Pfizer and BioNTech announced on Nov. 3 they will test a combined COVID-19 and influenza mRNA vaccine, which they claim will potentially lead to a better vaccine update for both diseases. The new vaccine will combine Pfizer’s quadrivalent mRNA-based flu shot, which is currently in Phase 3 clinical development, and Pfizer and BioNTech’s new bivalent booster […]